XATA Xrs Corporation (MM)

	OMB APPROVAL
	OMB Number: 3235-0145
	Expires: February 28, 2009
	Estimated average burden hours per response...14.5

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 4)*

XATA CORPORATION

(Name of Issuer)

Common Stock, Par Value $0.01 Per Share

983882 30 9

Howard S. Zeprun
Chief Administrative Officer and General Counsel
Trident Capital, Inc.
505 Hamilton Avenue
Palo Alto, CA 94301
Telephone: (650) 289-4400

Authorized to Receive Notices and Communications)

February 12, 2009

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ).

 

 

CUSIP No.		983882 30 9	13D

(1) Comprised of (a) 1,964,429 shares of Series B Preferred Stock, (b) 1,269,036 shares of Series C Preferred Stock, (c) 1,566,580 shares of Series D Preferred Stock, (d) 1,013,514 shares of Series E Preferred Stock, (e) warrants exercisable for an aggregate of 1,149,028 shares of Common Stock, (f) options exercisable for an aggregate of 30,000 shares of Common Stock and (g) 12,500 shares of restricted Common Stock. Each share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock (together, the “Preferred Stock”) is convertible into one share of Common Stock. Pursuant to the terms of an exchange agreement between the Issuer and the parties identified therein, dated as of February 12, 2009 (the “Exchange Agreement”), each share of outstanding Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, upon the satisfaction of the conditions set forth in the Exchange Agreement, including shareholder approval of a specified amendment to the Issuer’s articles of incorporation. The options and shares of restricted Common Stock are held for the benefit of Trident Capital Management-V, L.L.C. (“TCMV”) by Christopher P. Marshall, who is a member of, and a nominee for director of Xata Corporation of, TCMV, pursuant to the terms of its operating agreement. The shares of Preferred Stock are held by Trident Capital Fund-V, L.P., Trident Capital Fund V Affiliates Fund, L.P., Trident Capital Fund-V Affiliates Fund (Q), L.P., Trident Capital Fund-V Principals Fund, L.P. (collectively, the “Delaware Trident Entities”), and Trident Capital Parallel Fund-V, C.V. (“TCPV”). TCMV is the sole general partner of each of the Delaware Trident Entities and the sole investment partner of TCPV. Christopher P. Marshall disclaims beneficial ownership of these options and shares of Common Stock and Preferred Stock, except to the extent of his economic interests in each of the foregoing entities.

CUSIP No.		983882 30 9	13D

(2) Comprised of (a) 1,759,807 shares of Series B Preferred Stock, (b) 1,136,849 shares of Series C Preferred Stock, (c) 1,403,400 shares of Series D Preferred Stock, (d) 907,942 shares of Series E Preferred Stock, and (e) warrants exercisable for an aggregate of 1,029,341 shares of Common Stock. Each share of Preferred Stock is convertible into one share of Common Stock. As described above, each share of Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, pursuant to the terms of, and upon satisfaction of the conditions set forth in, the Exchange Agreement.

CUSIP No.		983882 30 9	13D

(3) Comprised of (a) 10,228 shares of Series B Preferred Stock, (b) 6,607 shares of Series C Preferred Stock, (c) 8,156 shares of Series D Preferred Stock, (d) 5,277 shares of Series E Preferred Stock and (e) warrants exercisable for an aggregate of 5,983 shares of Common Stock. Each share of Preferred Stock is convertible into one share of Common Stock. As described above, each share of Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, pursuant to the terms of, and upon satisfaction of the conditions set forth in, the Exchange Agreement.

CUSIP No.		983882 30 9	13D

(4) Comprised of (a) 9,758 shares of Series B Preferred Stock, (b) 6,305 shares of Series C Preferred Stock, (c) 7,783 shares of Series D Preferred Stock, (d) 5,036 shares of Series E Preferred Stock, and (e) warrants exercisable for an aggregate of 5,709 shares of Common Stock. Each share of Preferred Stock is convertible into one share of Common Stock. As described above, each share of Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, pursuant to the terms of, and upon satisfaction of the conditions set forth in, the Exchange Agreement.

CUSIP No.		983882 30 9	13D

(5) Comprised of (a) 50,936 shares of Series B Preferred Stock, (b) 32,905 shares of Series C Preferred Stock, (c) 40,620 shares of Series D Preferred Stock, (d) 26,279 shares of Series E Preferred Stock and (e) warrants exercisable for an aggregate of 29,793 shares of Common Stock. Each share of Preferred Stock is convertible into one share of Common Stock. As described above, each share of Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, pursuant to the terms of, and upon satisfaction of the conditions set forth in, the Exchange Agreement.

CUSIP No.		983882 30 9	13D

(6) Comprised of (a) 133,700 shares of Series B Preferred Stock, (b) 86,370 shares of Series C Preferred Stock, (c) 106,621 shares of Series D Preferred Stock, (d) 68,980 shares of Series E Preferred Stock and (e) warrants exercisable for an aggregate of 78,202 shares of Common Stock. Each share of Preferred Stock is convertible into one share of Common Stock. As described above, each share of Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, pursuant to the terms of, and upon satisfaction of the conditions set forth in, the Exchange Agreement.

Item 1. Security and Issuer.

This Amendment No. 4 amends and supplements that Statement on Schedule 13D (the “Statement”) filed by the parties on December 18, 2003, as amended and supplemented by Amendment No. 1 filed by the parties on September 21, 2005, Amendment No. 2 filed by the parties on March 23, 2007 and Amendment No. 3 filed by the parties on June 25, 2007, respectively, with respect to the common stock, par value $0.01 per share (“Common Stock”) of Xata Corporation, a Minnesota corporation (the “Issuer”). The principal executive office of the Issuer is located at 965 Prairie Center Drive, Eden Prairie, Minnesota 55344. The Common Stock is quoted on the NASDAQ Capital Market under the symbol “XATA”.

Item 2. Identity and Background.

(a)		Name:
		Trident Capital Management-V, L.L.C. (“TCMV”) Trident Capital Fund-V, L.P. (“TCV”) Trident Capital Fund-V Affiliates Fund, L.P. (“TCVA”) Trident Capital Fund-V Affiliates Fund (Q), L.P. (“TCVAQ”) Trident Capital Fund-V Principals Fund, L.P. (“TCVP”) Trident Capital Parallel Fund-V, C.V. (“TCPV,” and together with TCV, TCVA, TCVAQ and TCVP, the “Trident Entities”)
(b)		Residence or business address:
		Reporting Persons: 505 Hamilton Avenue, Suite 200, Palo Alto, CA 94301
(c)		TCMV serves as the sole general partner of TCV, TCVA, TCVAQ and TCVP and as the sole investment general partner of TCPV. TCV, TCVA, TCVAQ and TCVP are each Delaware limited partnerships whose principal business is investing in various companies. TCPV, whose principal business is also investing in various companies, was organized under the laws of the Netherlands.
(d)		During the last five years, neither the Trident Entities nor, to the best knowledge of the Trident Entities, any managing director of TCMV, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)		During the last five years, neither the Trident Entities nor, to the best knowledge of the Trident Entities, any managing director of TCMV, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)		Citizenship.

		TCMV:		Delaware
		TCV:		Delaware
		TCVA:		Delaware
		TCVAQ:		Delaware
		TCVP:		Delaware
		TCPV:		Netherlands

Item 3. Source and Amount of Funds or Other Consideration.

The Trident Entities purchased (a) an aggregate of 1,013,514 shares (the “Series E Shares”) of Series E Preferred Stock of the Issuer, no stated par value (the “Series E Preferred Stock”) from the Issuer in a private transaction on February 12, 2009 for a total purchase price of $2,250,001, and (b) warrants to acquire an aggregate of 304,054 shares of Common Stock for a total purchase price of $38,007. The Series E Shares are immediately convertible into an aggregate of 1,013,514 shares of Common

Stock. As described above, each share of Series E Preferred Stock shall automatically convert into one share of Series F Preferred Stock, pursuant to the terms of, and upon satisfaction of the conditions set forth in, the Exchange Agreement. The Trident Entities funded these purchases from working capital. None of the funds used for the purchase consisted of funds or other consideration borrowed.

Item 4. Purpose of Transaction.

The Trident Entities acquired the Issuer’s securities for investment purposes.

Subject to applicable legal requirements, the Trident Entities may purchase additional securities of the Issuer from time to time in open market or in private transactions, depending on their evaluation of Issuer’s business, prospects and financial condition, the market for the Issuer’s securities, other developments concerning Issuer, the reaction of Issuer to the Trident Entities’ ownership of the Issuer’s securities, other opportunities available to the Trident Entities, and general economic, money market and stock market conditions. In addition, depending upon the factors referred to above, the Trident Entities may dispose of all or a portion of their securities of the Issuer at any time. Each of the Trident Entities reserves the right to increase or decrease its or his holdings on such terms and at such times as each may decide.

Other than as described in this Item 4, the Trident Entities do not have any plan or proposal relating to or that would result in: (a) the acquisition by any person of additional securities of the Issuer or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the Board of Directors or management of the Issuer, including any plans or proposals to change the number or terms of directors or to fill any existing vacancies on the Board of Directors of the Issuer; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer’s business or corporate structure; (g) changes in the Issuer’s charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) a class of securities of the Issuer being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (j) any action similar to those enumerated above.

Item 5. Interest in Securities of the Issuer.

The following information with respect to the ownership of the Common Stock of the Issuer by the persons filing this Amendment No. 4 to Statement on Schedule 13D is provided as of February 13, 2009. Percentages are based on 8,775,769 shares of Common Stock reported outstanding as of January 30, 2009 on the Issuer’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2008, as filed with the Securities and Exchange Commission on February 4, 2009:

										Shared				Sole				Shared
		Shares Held				Sole Voting				Voting				Dispositive				Dispositive				Beneficial				Percentage
Reporting Persons		Directly				Power				Power				Power				Power				Ownership (7)				of Class
TCMV (1)			0				7,005,087				0				7,005,087				0				7,005,087				44.4	%
TCV (2)			6,237,339				6,237,339				0				6,237,339				0				6,237,339				41.6	%
TCVA (3)			36,251				36,251				0				36,251				0				36,251			less than 1%
TCVAQ (4)			34,591				34,591				0				34,591				0				34,591			less than 1%
TCVP (5)			180,533				180,533				0				180,533				0				180,533				2.0	%
TCPV (6)			473,873				473,873				0				473,873				0				473,873				5.1	%

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

On December 6, 2003, the Issuer entered into a Common Stock Warrant and Series B Preferred Stock Purchase Agreement (the “2003 Stock Purchase Agreement”) with the Trident Entities. On September 7, 2005, the Issuer entered into a Common Stock Warrant and Series C Preferred Stock Purchase Agreement (the “2005 Stock Purchase Agreement”) with the Trident Entities. On June 18, 2007, the Issuer entered into a Common Stock Warrant and Series D Preferred Stock Purchase Agreement with the Trident Entities (the “2007 Stock Purchase Agreement”). On February 12, 2009, the Issuer entered into a Common Stock Warrant and Series E Preferred Stock Purchase Agreement with the Trident Entities (the “2009 Stock Purchase Agreement,” and together with the 2003 Stock Purchase Agreement, the 2005 Stock Purchase Agreement and the 2007 Stock Purchase Agreement, the “Stock Purchase Agreements”).

Under the 2003 Stock Purchase Agreement, the Trident Entities purchased an aggregate of 1,612,903 shares of Series B Preferred Stock (the “Series B Preferred Stock”) for $4,096,774, or $2.54 per share. The price per share of the Series B Preferred Stock and the conversion price at which the Series B Preferred Stock converts into Common Stock were equal to the “market value” of the Common Stock (as defined in the rules of the NASDAQ Stock Market) on the date of execution of the 2003 Stock Purchase Agreement.

Under the 2005 Stock Purchase Agreement, the Trident Entities purchased an aggregate of 1,269,036 shares of Series C Preferred Stock (the “Series C Preferred Stock”) for $5,000,002, or $3.94 per share. The price per share of the Series C Preferred Stock and the conversion price at which the Series C Preferred Stock converts into Common Stock were equal to the “market value” of the Common Stock (as defined in the rules of the NASDAQ Stock Market) on the date of execution of the 2005 Stock Purchase Agreement.

Under the 2007 Stock Purchase Agreement, the Trident Entities purchased an aggregate of 1,566,580 shares of Series D Preferred Stock (the “Series D Preferred Stock”) for $6,000,001, or $3.83 per share. The price per share of the Series D Preferred Stock and the conversion price at which the Series D Preferred Stock converts into Common Stock were equal to the

“market value” of the Common Stock (as defined in the rules of the NASDAQ Stock Market) on the date of execution of the 2007 Stock Purchase Agreement.

Under the 2009 Stock Purchase Agreement, the Trident Entities purchased an aggregate of 1,013,514 shares of Series E Preferred Stock (the “Series E Preferred Stock,” and together with the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock, the “Preferred Stock”) for $2,250,001, or $2.22 per share. The price per share of the Series E Preferred Stock and the conversion price at which the Series E Preferred Stock converts into Common Stock were equal to the “market value” of the Common Stock (as defined in the rules of the NASDAQ Stock Market) on the date of execution of the 2009 Stock Purchase Agreement.

Each share of Preferred Stock is convertible into one share of the Issuer’s Common Stock.

The Series B Preferred Stock pays an annual cumulative dividend of 4% of the original issue price (payable, at the option of the holders, in additional shares of Preferred Stock rather than cash). The Preferred Stock has a non-participating preferred liquidation right equal to the original issue price plus accrued unpaid dividends, with the liquidation rights of (i) the Series B Preferred Stock being senior to those of the Series C Preferred Stock, the Series D Preferred Stock and the Series E Preferred Stock, (ii) the Series C Preferred Stock being senior to those of the Series D Preferred Stock and Series E Preferred Stock and (iii) the Series D Preferred Stock being senior to those of the Series E Preferred Stock. As further described below, pursuant to the terms of the Exchange Agreement, upon and subject to shareholder approval of an amendment to the Issuer’s articles of incorporation, (i) each share of Series E Preferred Stock shall convert into one share of Series F Preferred Stock (the “Series F Preferred Stock”) and thereafter no shares of Series E Preferred Stock shall be authorized for issuance under the Issuer’s articles of incorporation, (ii) the Series F Preferred Stock shall be senior to the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock in respect of liquidation preference and (iii) subject to the senior accumulating dividend rights of the Series B Preferred Stock, the Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock shall have pari passu dividend rights.

The Preferred Stock is redeemable by the Issuer, after five (5) years from the original issuance of the respective shares of Preferred Stock, at the original issue price plus accrued unpaid dividends, if the market value of the Common Stock is at least three (3) times the then effective conversion price for a specified period. The Issuer is required to redeem the Preferred Stock in certain events described therein, including default on debt, significant adverse judgments in litigation, bankruptcy, or a Change in Control (as defined in Section 4(D) of the Certificate of Designation pertaining to the Series B Preferred Stock). So long at least 325,000 shares of the Issuer’s Series B Preferred Stock remain outstanding, the holders of Series B Preferred Stock are entitled to vote as a class to elect two (2) members of the Issuer’s Board of Directors.

Pursuant to the 2003 Stock Purchase Agreement, the Issuer issued to the Trident Entities 5-year warrants, which have now expired, to purchase an aggregate of 451,226 shares of the Issuer’s Common Stock at an exercise price of $3.17 per share for an aggregate purchase price of $56,403. Pursuant to the 2005 Stock Purchase Agreement, the Issuer issued to the Trident Entities 5-year warrants, which exercise period was subsequently extended an additional two years, to purchase an aggregate of 375,000 shares of the Issuer’s Common Stock at an exercise price of $3.94 per share for an aggregate purchase price of $46,875. Pursuant to the 2007 Stock Purchase Agreement, the Issuer issued to the Trident Entities 5-year warrants, which exercise period was subsequently extended an additional two years, to purchase an aggregate of 469,974 shares of the Issuer’s Common Stock at an exercise price of $3.83 per share for an aggregate purchase price of $58,747. Pursuant to the 2009 Stock Purchase Agreement, the Issuer issued to the Trident Entities 7-year warrants to purchase an aggregate of 304,054 shares of the Issuer’s Common Stock at an exercise price of $2.22 per share for an aggregate purchase price of $38,007. These warrants permit cashless exercise.

The Trident Entities have been advised by the Issuer that the Issuer will use the cash proceeds from the sale of the Series E Shares and the related warrants for working capital and general corporate purposes.

Ancillary agreements include (a) indemnification agreements for the Trident Entities and their representatives on the Board (see below), (b) a voting agreement between the Trident Entities and each of John Deere Special Technologies Group, Inc. and William P. Flies (each a major shareholder), which includes a right of first refusal, (c) an investor rights agreement between the Issuer and the Trident Entities and (d) an exchange agreement between the Issuer and the parties identified therein.

Under the terms of the voting agreement, if the Trident Entities are no longer able to elect two (2) members of the Issuer’s Board of Directors as provided in the Certificate of Designation, so long as the Trident Entities hold at least 800,000 common stock equivalents, the parties to the voting agreement agree to vote all shares of capital stock held by them for the election of designees of the Trident Entities as follows: (a) if the authorized size of the Issuer’s Board of Directors is at least eight members, then the Trident Entities may designate two persons for the election of directors; and (b) if the authorized size of the Issuer’s Board of Directors is seven or fewer members, then the Trident Entities may designate one person for the election of directors and all parties agree to vote for a second member who is nominated by the Trident entities, acceptable to a majority of the remaining members of the Board of Directors, an industry representative, and not affiliated with the Issuer. The voting agreement also provides that the Issuer will not take any action to increase the authorized number of shares of Series B Preferred Stock or Series C Preferred Stock without the written consent of holders of at least 60% of the Series B Preferred

Stock or Series C Preferred Stock, as applicable. Additionally, subject to certain limitations, the voting agreement provides that the Issuer will use its best efforts to cause its Board of Directors to appoint at least one of the Trident Entities’ designees to Board of Directors to each of the committees of the Board of Directors.

Under the investor rights agreement, the Trident Entities have a right of first refusal on certain issuances of stock of the Issuer, certain rights to financial information, and certain inspection rights. The Issuer has also agreed that it will not, without first obtaining the approval of holders of a majority in interest of the shares held by the Trident Entities, (a) enter into transactions with the Issuer’s affiliates except upon terms that are at least as favorable to the Issuer as could be obtained in a transaction with unaffiliated or disinterested parties; (b) create or issue any class or series of stock or other securities convertible into equity securities having any right, preference or privilege senior to or on a parity with any series of preferred stock then held by the Trident Entities, except for shares of Series F Preferred Stock issuable pursuant to the Exchange Agreement; (c) adversely change the rights of, or increase the authorized number of shares of, the Preferred Stock; (d) enter into any bankruptcy filing, liquidation, assignment for the benefit of creditors, or similar event; (e) redeem, repurchase, pay or declare dividends or make any distribution on capital stock other than the Preferred Stock; or (f) subject to certain limitations and exceptions, issue or sell, or be deemed to have issued or sold, Common Stock for an effective price less than the fair market value of the Common Stock, unless at the time of the action the Trident Entities and their affiliates hold less than a requisite number of shares of the Issuer’s capital stock. The Issuer also has agreed to limit, in certain circumstances, the terms of registration rights granted after the date of the 2005 Stock Purchase Agreement. The Issuer further agreed to consult, in good faith, with the Trident Entities on matters relating to termination or selection of the Issuer’s president or chief executive officer and to maintain director and officer liability insurance in an amount not less than $3,000,000, unless the Trident Entities consent to a lower amount.

As promptly as practicable after entering into the Exchange Agreement, the Issuer is obligated to call and hold a meeting of its shareholders to approve an amendment to its articles of amendment to, among other things, authorize the Series F Preferred Stock, which would have a liquidation preference senior to the Issuer’s existing series of preferred stock. Under the Exchange Agreement, pursuant to the terms of, and upon satisfaction of the conditions contained in, such agreement, including shareholder approval of the foregoing amendment to the Issuer’s articles of incorporation, the Issuer would issue to the purchasers of Series E Preferred Stock shares of newly issued Series F Preferred Stock and such parties would transfer all of the then outstanding shares of Series E Preferred Stock held thereby to the Issuer in exchange therefor.

In addition, pursuant to the 2003 Stock Purchase Agreement and 2005 Stock Purchase Agreement, the Issuer filed Registration Statements on Form S-3 to register the resale, from time to time, of the Common Stock to be issued pursuant to conversion of the Series B Preferred Stock and Series C Preferred Stock and exercise of the warrants issued pursuant to the 2003 Stock Purchase Agreement and 2005 Stock Purchase Agreement, and a reasonable estimate of any Common Stock to be issued as dividends on the Series B Preferred Stock. Pursuant to the 2007 Stock Purchase Agreement, the Issuer has agreed to file a Registration Statement on Form S-3 to register the resale, from time to time, of the Common Stock to be issued pursuant to conversion of the Series D Preferred Stock and exercise of the warrants issued pursuant to the 2007 Stock Purchase Agreement. Pursuant to the 2009 Stock Purchase Agreement, the Issuer has agreed to file a Registration Statement on Form S-3 to register the resale, from time to time, of the Common Stock to be issued pursuant to conversion of the Series E Preferred Stock or Series F Preferred Stock, as applicable, and exercise of the warrants issued pursuant to the 2009 Stock Purchase Agreement.

Pursuant to the terms of the 2003 Stock Purchase Agreement, Trident has currently named one representative, Christopher P. Marshall, to the Issuer’s Board of Directors.

Item 7. Material to Be Filed as Exhibits.

Exhibit		Description
A		Agreement regarding filing of joint Schedule 13D.
3.1		Certificate of Designation for Series E Preferred Stock, dated February 12, 2009*
4.1		Amended and Restated Investor Rights Agreement, dated February 12, 2009*
4.2		Form of Warrant*
10.1		Common Stock Warrant and Series E Preferred Stock Purchase Agreement, dated February 12, 2009*
10.2		Exchange Agreement, dated February 12, 2009*

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2009

		Trident Capital Fund-V, L.P. Trident Capital Fund-V Affiliates Fund, L.P. Trident Capital Fund-V Affiliates Fund (Q), L.P. Trident Capital Fund-V Principals Fund, L.P.
		Executed on behalf of the foregoing funds by the undersigned as an authorized signatory of Trident Capital Management-V, L.L.C., which serves as the sole general partner of each such fund, and on behalf of Trident Capital Management-V, L.L.C.:
		/s/ Donald R. Dixon
		Signature
		Donald R. Dixon, Managing Director
		Name/Title
		Trident Capital Parallel Fund-V, C.V. Executed on behalf of Trident Capital Parallel Fund-V, C.V. by the undersigned as an authorized signatory of Trident Capital Management-V, L.L.C., which serves as its sole investment partner:
		/s/ Donald R. Dixon
		Signature
		Donald R. Dixon, Managing Director
		Name/Title

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001)

EXHIBIT A

Joint Filing Statement

We, the undersigned, hereby express our agreement that the attached Schedule 13D (and any amendments thereto) relating to the Common Stock of Xata Corporation is filed on behalf of each of the undersigned.

Date: February 14, 2009

     

		Trident Capital Fund-V, L.P. Trident Capital Fund-V Affiliates Fund, L.P. Trident Capital Fund-V Affiliates Fund (Q), L.P. Trident Capital Fund-V Principals Fund, L.P.
		Executed on behalf of the foregoing funds by the undersigned as an authorized signatory of Trident Capital Management-V, L.L.C., which serves as the sole general partner of each such fund, and on behalf of Trident Capital Management-V, L.L.C.:
		/s/ Donald R. Dixon
		Signature
		Donald R. Dixon, Managing Director
		Name/Title
		Trident Capital Parallel Fund-V, C.V. Executed on behalf of Trident Capital Parallel Fund-V, C.V. by the undersigned as an authorized signatory of Trident Capital Management-V, L.L.C., which serves as its sole investment partner:
		/s/ Donald R. Dixon
		Signature
		Donald R. Dixon, Managing Director
		Name/Title

Xata (NASDAQ:XATA)
Historical Stock Chart
From Jul 2024 to Jul 2024

Xata (NASDAQ:XATA)
Historical Stock Chart
From Jul 2023 to Jul 2024